Mushrooms Inc (MSRM)

[2times2]

Mushrooms Inc. CEO, Kimberly Carlson, Discusses Exciting Potential of Industrial Mushroom Industry on Psychedelic Spotlight Podcast.

Estero, FL, July 19, 2023 – Mushrooms Inc. (OTC: MSRM) (the “Company” or “MSRM) is pleased to announce that its CEO, Kimberly Carlson, recently appeared on the esteemed Psychedelic Spotlight Podcast to discuss the exciting potential of the industrial mushroom industry. As the first company trading on the US stock market focused on the industrial side of mushrooms, Mushrooms Inc. is leading the way in revolutionizing this emerging sector.

To watch or listen to the complete interview featuring Kimberly Carlson on Psychedelic Spotlight, please visit the following link: https://psychedelicspotlight.com/using-mycelium-for-a-sustainable-future-feat-kimberly-carlson/

During the podcast episode hosted by David Flores (CEO of Psychedelic Spotlight), Kimberly Carlson shared insights into the vision and mission of Mushrooms Inc. The Company is dedicated to supporting the growth of the mushroom industry through collaboration, innovation, and development. At the heart of Mushrooms Inc. lies a commitment to creating and supporting environmentally beneficial product innovation.

With a specific focus on the industrial application of mycelium, Mushrooms Inc. aims to develop carbon-neutral products for the building, textile, and healthcare industries. By harnessing the power of mycology, Mushrooms Inc. seeks to advance the creation of scientifically proven products that promote the health of the body, mind, and environment which includes remediation of toxic substances using mycelium also known as Myco-remediation.

Along with providing Mr. Flores with an overview of Mushrooms Inc., Ms. Carlson also shared insight into her own personal passion for working within the mushroom sector and why she believes mycelium holds the potential to promote a healthier and more sustainable environment for all of society.

"The potential of the industrial mushroom sector is immense, and Mushrooms Inc. is at the forefront of driving innovation in this field," said Kimberly Carlson, CEO of Mushrooms Inc. "Through our research and development efforts, we are committed to delivering sustainable solutions that benefit not only our customers but also the planet.

I am grateful for the opportunity to have had Mushrooms Inc. featured on the Psychedelic Spotlight Podcast, and more specifically, for the opportunity to provide their audience, as well as many others following the public markets, with an initial introduction into some the exiting things we have planned for MSRM.



In the weeks and months ahead, I look forward to being able to share some of the progress we anticipate making as we strive to truly position MSRM as an industrial mushroom leader.”

Mushrooms Inc. recognizes that true innovation comes from collaboration and learning from pioneers in the field. By fostering working relationships and engaging with experts in mycology, the Company is paving the way for groundbreaking advancements in the industry.

For more information about Mushrooms Inc., please email [e-mail] or visit www.mushroomsinc.com.

[i_like_bb_stock]

super low floater with a co. names Mushrooms Inc you bet itll get attention eventually or bought https://www.globenewswire.com/news-release/2023/07/19/2707379/0/en/Mushrooms-Inc-CEO-Kimberly-Carlson-Discusses-Exciting-Potential-of-Industrial-Mushroom-Industry-on-Psychedelic-Spotlight-Podcast.html

[2times2]

Market Cap Market Cap 762,018 07/13/2023
Outstanding Shares 38,485,760 07/13/2023
Restricted 32,527,735 07/13/2023
Unrestricted 5,958,025 07/13/2023

[2times2]

Market cap $670k (or if one just takes unrestricted shares into account $102k)...the CEO is right now working on contracts...a no brainer to buy and hold until the pps shoots up

[Johnstown]

$MSRM .0159 new LOY, still waiting for the real updates, other then dumping shares by the co

[Johnstown]

MSRM .171 new LOY, and these psychs, are playing with your brain, this is a share selling scam, and has been since day 1, updates coming, lol, more like continuous DILUTION coming that is all this SHROOM play has done

[BillyBarty14]

ROCK ON! as this matures and the industry evolves, psychs are going to be riding a wave.

[gains4us]

From the horse's mouth: "UPDATES COMING SOON"

[i_like_bb_stock]

BREAKING: The California Senate passed a bill to legalize possession of psychedelics like psilocybin, DMT, ibogaine and mescaline.https://t.co/TlaZDSdPRb pic.twitter.com/2tN4qSEuBR

— Tom Angell 🌳📰ⓥ (@tomangell) May 24, 2023

[2times2]

no dilution (Outstanding Shares 37,985,760 05/18/2023) with most restricted
(32,782,535 05/18/2023)....and, indeed nice absorption of 500K today without pps decline!

[Johnstown]

MSRM .0244 nice 500k dump, but no movement, more dilution, smh

[2times2]

Recent tweet asks for our input (Seems like we will get updates soon):

[2times2]

MSRM: Update & Acquisitions...Unrestricted shares preserved at 4.8M
Mushrooms Inc. (OTC: MSRM) Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market LeadersPress Release | 02/23/2023
ESTERO, FL / ACCESSWIRE / February 23, 2023 / Mushrooms, Inc. (OTC PINK:MSRM) (the "Company") has been quietly making progress within this exciting multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology.
Mushrooms Inc. is developing profitable pathways to sustain the research and development branch which is necessary to achieve viable industrial innovation in this new field.
MSRM is targeting grants specific to their goals, working with pioneers, scientists, and universities, on a global scale to develop scientifically proven products that advance health of body, mind, and environment. They have multiple proposals that they are currently reviewing for their costs to bring to market, timelines, scalability, as well as their positive financial, environmental and health impact. These proposals include a patentable process for the development of mycelium-based building supplies, a patentable process for mushroom related cosmetic and anti-aging skin products, a superfood product not currently seen in the marketplace as well as several remediation projects with new product innovation as an end result. These proposals are being assessed while keeping the progress on an off-shore lab and scientists for an evolved patentable mycelium thread.

GROWTH STRATEGY
In order to offset research costs and time on the industrial development side we are establishing pillars of development outside of the industrial mushroom market through acquisitions and joint ventures. The business model is based on the amazing qualities of mycelium and its networking capabilities as well as its ability to benefit from the network its developing.

CEO Kimberly Carlson shared, "I have been fortunate to connect with amazing pioneers and innovators in differing areas of the Mushroom Market in the US and abroad. Three realities have been consistent with the people behind the businesses and their processes. One is that this business model can bring like-minded companies together in order to benefit and fruit from a shared network under the public umbrella. Secondly, there are natural and substantial cross-points between these companies to mutually benefit from each other while growing as a whole. And the third is that there is a desire for many of these businesses to unite their expertise to others and share from a unified gain. By combining the power of shared ideals and resources through joint ventures, we can move as larger more developed companies do, but without limiting quality and compassion for social and environmental governance."

With a focus on profitability and mutually beneficial cross points, MSRM is assessing partnerships with complimentary businesses which would strategically advance the Company's reach into related markets through joint ventures and M&A activity.
Establishing pillars of development outside of the industrial mushroom market allows for a broad scope of proven profitability and cross-sharing of resources.
We seek to enter partnerships in the Cultivation Market, which includes substrate, spawn production, and fruiting. Cultivation gives life to all market pillars to some degree. It feeds directly into the Mushroom Nutraceutical and Medicinal Psylocibin Market with the addition of extraction, quality testing, product development, and processing. The Medicinal Mushroom Market requires legalization and branches into wellness retreats, treatment certifications and clinics.

MSRM is also evaluating several companies involved in the Myco-Remediation Market which uses fungi to clean oil spills, heavy metals, plastics and other pollutants from soil, water, and the atmosphere. All of these markets relate to the industrial and health innovation that the Company is pursuing in differing aspects and creates a connecting point for acceleration, mutual benefit and market share.
It is the belief of MSRM that connecting these pillars of the mushroom market through joint ventures and acquisitions, while focusing their innovation efforts on the industrial side of the market, will garner cross benefits financially and accelerate timelines during the major research and development phases.
We are simultaneously creating a vertically integrated business model for the businesses involved by aligning strengths between the companies under the umbrella of MSRM.
From an investor perspective, we are creating an avenue for investors to support a larger portion of the mushroom market, establishing a broader financial base of support for and from the networked companies while allowing for a more elastic ability to pivot, expand and connect to new industry pathways as they surface.

Market Opportunity
Mushrooms, Inc. operates in the North American segment of the functional mushroom market in the mycelium material and mushroom supplement product types. According to various industrial research firms, the global functional mushroom market is projected to show a compounded annual growth rate of over 9% for the next five years (Industry Arc and Vantage Market Research). The North American edible mushroom market was worth 11.99 billion in 2023 and is growing at a compounded annual growth rate of 9.48%, forecast to reach 20.91 billion by 2028 (Market Data Forecast). The North American functional mushroom market held 33.8% of the global market in 2020 and is growing at a compounded annual growth rate of 7% (Industry Arc).

Overview
Mushrooms, Inc. is a developing-stage emerging consumer products platform focused on the manufacturing and marketing of highly differentiated mushroom-based materials and functional supplements. The core growth pillars of the Mushrooms, Inc. platform are currently based on developing functional mushroom technologies. As a result of growing consumer demand for innovative, sustainable, and carbon-neutral products, Mushrooms, Inc. plans to grow revenues by penetrating the multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology, as well as expanding our platform to include the creation of supplements based on the proven health benefits of mushrooms.
Mushrooms, Inc. seeks to drive the growth of the bourgeoning functional mushroom industry through product innovation and development. Our current core business activity is environmentally beneficial product innovation utilizing self-growing, fibrous, and natural composite materials with controlled physical properties that can be produced in large quantities. Our product technologies focus on mycelium, the main component of fungi. This emerging biotechnology is used in the creation of carbon neutral products for the building, textile, packaging, and health care industries, as well as in the creation of supplements based on the proven health benefits of mushrooms.

Currently, our research focuses primarily on the significant thermal stability of mycelium materials, a result of mycelium's unique degradation qualities that expand the potential fields of application for mushroom-based products. Mushrooms, Inc.'s long-term goal is to build a strong scalable and widely recognized brand that authentically focuses on sustainable mushroom ingredients and novel functionality stemming from innovative biotech and materials science.
For more information, email [e-mail] or visit www.mushroomsinc.com

04/20/2023 Quarterly Report for the period ended March31, 2023
03/06/2023 Attorney Letter with Respect to Current Information - Shell Status Opinion MSRM
03/06/2023 Attorney Letter with Respect to Current Information - MSRM - Current Information Letter
03/06/2023 Annual Report - MSRM 2022 Annual Report
https://www.otcmarkets.com/stock/MSRM/disclosure

Outstanding Shares 37,985,760 04/22/2023
Restricted 33,162,392 04/22/2023
Unrestricted 4,823,368 04/22/2023

update by CEO:
see twitter https://twitter.com/MushroomsInc

MSRM This is totally under the Radar and is REAL. Check the SS , they did file a Patent that is coming up , they do have the product and their Mgt Team actually knows what they are doing.
https://otcmarkets.com/stock/MSRM/security
https://mushroomsinc.com/team-3
https://twitter.com/MushroomsInc

[2times2]

Outstanding Shares 37,985,760 04/12/2023
Restricted 33,162,392 04/12/2023
Unrestricted 4,823,368 04/12/2023

[2times2]

Outstanding Shares 36,397,686 03/19/2023
Restricted 31,574,318 03/19/2023
Unrestricted 4,823,368 03/19/2023

[2times2]

Annual Report out...Unrestricted preserved at 4.6M:

03/06/2023 Attorney Letter with Respect to Current Information - Shell Status Opinion MSRM
03/06/2023 Attorney Letter with Respect to Current Information - MSRM - Current Information Letter
03/06/2023 Annual Report - MSRM 2022 Annual Report
https://www.otcmarkets.com/stock/MSRM/disclosure

[Stepbro69]

Shell badge gone soon?

[2times2]

agreed

[gains4us]

CEO is serious PLUS updates regularly and preserves the SS while getting the company out of the starting blocks

[i_like_bb_stock]

thx

[2times2]

update by CEO:

see twitter https://twitter.com/MushroomsInc

[mikenelson01]

Nice to see are not selling off MSRM. Be nice to see another push next week.

[Zardiw]

#DDAmanda Chart on $MSRM:



Z

[Stepbro69]

I do not have private message,

Can I find you on twitter?

[Zardiw]

So what is the scamming company moving under the Umbrella here?

Z

[Stepbro69]

Agreed, this has a bright future . Especially being on the cusp of the shroom boom. It will be massive

[MallenNV]

Another UMBRELLA scam. Hers how it works

It allows scammers who don’t want to or can’t go public for what ever the reason. They latch onto a public vehicle and acquire free trading shares that promise to jump start the liquidity and price but when they pump and stock UP and sell off all the free shares they received (usually in a day or two or a few months), once sold they vanish and leave the company and CEO to deal with the diluted shares and eventually the huge drop in share price and then people ask the CEO what happened to the HOT news and plans.

Its the same as a pump and dump but the pump is from non company affiliates who told the CEO if they issue then shares they will put the alleged company under the public vehicles umbrella. What that means is a scammer who can’t go public can just form some new LLC (private company) that is not real but a simple website and they look like a giant company, start a PR pump and dump, send out the pumpers to chat rooms, sell off the free shares they got from the CEO with the promise it will make that public company a huge success.

UMBRELLA is just a way scammers can sell publicly traded shares and have clean hands and make as much money as they would being a public pump and dump only they are not the ones public yet they market that their plan is part of the public company.

Mushrooms Inc. (OTC: MSRM) Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market Leaders

CEO Kimberly Carlson shared, "I have been fortunate to connect with amazing pioneers and innovators in differing areas of the Mushroom Market in the US and abroad. Three realities have been consistent with the people behind the businesses and their processes. One is that this business model can bring like-minded companies together in order to benefit and fruit from a shared network under the public umbrella.

[2times2]

under new management and new direction since last year this company has not added 1 share to the OS....a few restricted shares, held by previous insiders/employees, were converted from restricted to unrestricted...can't call that dilution and is not in the hands of the current management :) TINY FLOAT, NO DILUTION, NO CHANGE IN OS

[Johnstown]

$MSRM .0263 news and dilution go hand in hand with this ticker, done nothing but sell shares continuously for the last 3 mos, not a ton, but every single day, will probably be RED when the day is done, 650k traded vs 10 day ave of 120k

[2times2]

saw that...great update, indeed - wouldn't call it merger, though...steady wins the race...btw OTCX and CDEL just backed off on L2 in terms of shares offered = we might see the real ask and break through these last few shares

[gains4us]

Seems like a bunch of folks are lurking, since today there are various tweets to MSRM incl reference to "merger" news

[Stepbro69]

If it drops I will add more

[i_like_bb_stock]

yep a bit over 4 million float

[Stepbro69]

I discovered this last week and was going to enter but didn’t get around to it, as I am a big mushroom advocate and I know where this sector is headed. I happily chased this morning. 4 million float? I’ll hold till it moves back to dollars

[gains4us]

Looking at the SS and chart this could be a run away train soon. I got a solid stack

[i_like_bb_stock]

agreed

[2times2]

The float is tiny, the management transparent and reliably staying current, no convertible loans are being taken out, the business concept fantastic...and that lovely name, indeed - broad application of mushroom products is the future in a variety of fields

[i_like_bb_stock]

moving on air Mushrooms will be the MJ and its very early you dont get a better name than Mushrooms Inc with a 4M float

[2times2]

Mushrooms Inc. (OTC: MSRM) Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market Leaders Press Release | 02/23/2023

ESTERO, FL / ACCESSWIRE / February 23, 2023 / Mushrooms, Inc. (OTC PINK:MSRM) (the "Company") has been quietly making progress within this exciting multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology.

Mushrooms Inc. is developing profitable pathways to sustain the research and development branch which is necessary to achieve viable industrial innovation in this new field.

MSRM is targeting grants specific to their goals, working with pioneers, scientists, and universities, on a global scale to develop scientifically proven products that advance health of body, mind, and environment. They have multiple proposals that they are currently reviewing for their costs to bring to market, timelines, scalability, as well as their positive financial, environmental and health impact. These proposals include a patentable process for the development of mycelium-based building supplies, a patentable process for mushroom related cosmetic and anti-aging skin products, a superfood product not currently seen in the marketplace as well as several remediation projects with new product innovation as an end result. These proposals are being assessed while keeping the progress on an off-shore lab and scientists for an evolved patentable mycelium thread.

GROWTH STRATEGY
In order to offset research costs and time on the industrial development side we are establishing pillars of development outside of the industrial mushroom market through acquisitions and joint ventures. The business model is based on the amazing qualities of mycelium and its networking capabilities as well as its ability to benefit from the network its developing.

CEO Kimberly Carlson shared, "I have been fortunate to connect with amazing pioneers and innovators in differing areas of the Mushroom Market in the US and abroad. Three realities have been consistent with the people behind the businesses and their processes. One is that this business model can bring like-minded companies together in order to benefit and fruit from a shared network under the public umbrella. Secondly, there are natural and substantial cross-points between these companies to mutually benefit from each other while growing as a whole. And the third is that there is a desire for many of these businesses to unite their expertise to others and share from a unified gain. By combining the power of shared ideals and resources through joint ventures, we can move as larger more developed companies do, but without limiting quality and compassion for social and environmental governance."

With a focus on profitability and mutually beneficial cross points, MSRM is assessing partnerships with complimentary businesses which would strategically advance the Company's reach into related markets through joint ventures and M&A activity.

Establishing pillars of development outside of the industrial mushroom market allows for a broad scope of proven profitability and cross-sharing of resources.

We seek to enter partnerships in the Cultivation Market, which includes substrate, spawn production, and fruiting. Cultivation gives life to all market pillars to some degree. It feeds directly into the Mushroom Nutraceutical and Medicinal Psylocibin Market with the addition of extraction, quality testing, product development, and processing. The Medicinal Mushroom Market requires legalization and branches into wellness retreats, treatment certifications and clinics.

MSRM is also evaluating several companies involved in the Myco-Remediation Market which uses fungi to clean oil spills, heavy metals, plastics and other pollutants from soil, water, and the atmosphere. All of these markets relate to the industrial and health innovation that the Company is pursuing in differing aspects and creates a connecting point for acceleration, mutual benefit and market share.

It is the belief of MSRM that connecting these pillars of the mushroom market through joint ventures and acquisitions, while focusing their innovation efforts on the industrial side of the market, will garner cross benefits financially and accelerate timelines during the major research and development phases.

We are simultaneously creating a vertically integrated business model for the businesses involved by aligning strengths between the companies under the umbrella of MSRM.

From an investor perspective, we are creating an avenue for investors to support a larger portion of the mushroom market, establishing a broader financial base of support for and from the networked companies while allowing for a more elastic ability to pivot, expand and connect to new industry pathways as they surface.

Market Opportunity
Mushrooms, Inc. operates in the North American segment of the functional mushroom market in the mycelium material and mushroom supplement product types. According to various industrial research firms, the global functional mushroom market is projected to show a compounded annual growth rate of over 9% for the next five years (Industry Arc and Vantage Market Research). The North American edible mushroom market was worth 11.99 billion in 2023 and is growing at a compounded annual growth rate of 9.48%, forecast to reach 20.91 billion by 2028 (Market Data Forecast). The North American functional mushroom market held 33.8% of the global market in 2020 and is growing at a compounded annual growth rate of 7% (Industry Arc).

Overview
Mushrooms, Inc. is a developing-stage emerging consumer products platform focused on the manufacturing and marketing of highly differentiated mushroom-based materials and functional supplements. The core growth pillars of the Mushrooms, Inc. platform are currently based on developing functional mushroom technologies. As a result of growing consumer demand for innovative, sustainable, and carbon-neutral products, Mushrooms, Inc. plans to grow revenues by penetrating the multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology, as well as expanding our platform to include the creation of supplements based on the proven health benefits of mushrooms.

Mushrooms, Inc. seeks to drive the growth of the bourgeoning functional mushroom industry through product innovation and development. Our current core business activity is environmentally beneficial product innovation utilizing self-growing, fibrous, and natural composite materials with controlled physical properties that can be produced in large quantities. Our product technologies focus on mycelium, the main component of fungi. This emerging biotechnology is used in the creation of carbon neutral products for the building, textile, packaging, and health care industries, as well as in the creation of supplements based on the proven health benefits of mushrooms.

Currently, our research focuses primarily on the significant thermal stability of mycelium materials, a result of mycelium's unique degradation qualities that expand the potential fields of application for mushroom-based products. Mushrooms, Inc.'s long-term goal is to build a strong scalable and widely recognized brand that authentically focuses on sustainable mushroom ingredients and novel functionality stemming from innovative biotech and materials science.

For more information, email [e-mail] or visit www.mushroomsinc.com

[i_like_bb_stock]

news https://www.otcmarkets.com/stock/MSRM/news?id=390996

[2times2]

No brainer to invest in this technology:

[gains4us]

Helpful! Thanks

[Timing101]

Here you go
--
Lets see
--
$MSRM This is totally under the Radar and is REAL. Check the SS , they did file a Patent that is coming up , they do have the product and their Mgt Team actually knows what they are doing. Here you go .
https://otcmarkets.com/stock/MSRM/security
https://mushroomsinc.com/team-3
https://twitter.com/MushroomsInc

[2times2]

Again, look at business concept, tiny float, shares held by management, chart, filings...IMO news and updates are just a matter of time. Bottom is in IMO

[i_like_bb_stock]

dont know but its so cheap

[gains4us]

Updates coming as far as you are aware of?

[i_like_bb_stock]

The only ones selling are selling to chase something else requires patience but just the name will make it worth so much more

[2times2]

OS remained the same for months and months...not diluting...a few restricted went into the float - that's all - and not surprising while management ramps up the business...website updated...concept of use of mushrooms leads to endless possibilities

[2times2]

Market Cap 727,954 02/02/2023
Authorized Shares 400,000,000 02/01/2023
Outstanding Shares 36,397,686 02/01/2023
Restricted 32,125,947 02/01/2023
Unrestricted 4,271,739 02/01/2023

[i_like_bb_stock]

nope not diluting people bored getting out mushrooms.com will be worth something in them selves not a fast trade patience trade